Spatial collocation and venture capital in the US biotechnology industry

C Kolympiris, N Kalaitzandonakes, D Miller - Research Policy, 2011 - Elsevier
Biotechnology firms operate in a high-risk and high-reward environment and are in a
constant race to secure venture capital (VC) funds. Previous contributions to the literature …
被引用次数：90 相关文章

Spatial collocation and venture capital in the US biotechnology industry

C Kolympiris, N Kalaitzandonakes, D Miller - Research Policy, 2011 - infona.pl
Biotechnology firms operate in a high-risk and high-reward environment and are in a
constant race to secure venture capital (VC) funds. Previous contributions to the literature …

Spatial collocation and venture capital in the US biotechnology industry

C Kolympiris, N Kalaitzandonakes… - Research …, 2011 - researchportal.bath.ac.uk
Biotechnology firms operate in a high-risk and high-reward environment and are in a
constant race to secure venture capital (VC) funds. Previous contributions to the literature …

Spatial collocation and venture capital in the US biotechnology industry

C Kolympiris, N Kalaitzandonakes, D Miller - Research Policy, 2011 - econpapers.repec.org
Biotechnology firms operate in a high-risk and high-reward environment and are in a
constant race to secure venture capital (VC) funds. Previous contributions to the literature …

Spatial collocation and venture capital in the US biotechnology industry

C Kolympiris, N Kalaitzandonakes, D Miller - Research Policy, 2011 - wrap.warwick.ac.uk
Biotechnology firms operate in a high-risk and high-reward environment and are in a
constant race to secure venture capital (VC) funds. Previous contributions to the literature …

Spatial Collocation and venture capital in the US biotechnology industry

C Kolympiris, N Kalaitzandonakes, D Miller - Research Policy, 2011 - research.wur.nl
Biotechnology firms operate in a high-risk and high-reward environment and are in a
constant race to secure venture capital (VC) funds. Previous contributions to the literature …

Spatial collocation and venture capital in the US biotechnology industry

C Kolympiris, N Kalaitzandonakes, D Miller - Research Policy, 2011 - ideas.repec.org
Biotechnology firms operate in a high-risk and high-reward environment and are in a
constant race to secure venture capital (VC) funds. Previous contributions to the literature …

Spatial Collocation and venture capital in the US biotechnology industry

C Kolympiris, N Kalaitzandonakes, D Miller - Research Policy, 2011 - library.wur.nl
Biotechnology firms operate in a high-risk and high-reward environment and are in a
constant race to secure venture capital (VC) funds. Previous contributions to the literature …

Spatial collocation and venture capital in the US biotechnology industry

C Kolympiris, N Kalaitzandonakes, D Miller - Research Policy, 2011 - infona.pl
Biotechnology firms operate in a high-risk and high-reward environment and are in a
constant race to secure venture capital (VC) funds. Previous contributions to the literature …